Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
AstraZeneca probes 'mistake' behind 90% COVID-19 vaccine efficacy
Fierce Biotech
Tue, 11/24/20 - 10:35 am
AstraZeneca
clinical trials
vaccines
COVID-19
AZD1222
CureVac inks manufacturing deal with Wacker for its COVID-19 vaccine candidate
Biopharma Reporter
Tue, 11/24/20 - 10:31 am
CureVac
Wacker Chemie
COVID-19
vaccines
MRNA
CVnCoV
Moderna to file COVID-19 shot for emergency nod in November, with Pfizer rollout pegged for early next month: Slaoui
Fierce Pharma
Mon, 11/23/20 - 10:37 pm
Operation Warp Speed
Moncef Slaoui
Pfizer
Moderna Therapeutics
vaccines
COVID-19
Novavax’s COVID-19 Vaccine Shows Efficacy in Monkeys, but Does That Translate to Humans?
BioSpace
Mon, 11/23/20 - 10:30 pm
Novavax
vaccines
COVID-19
NVX-CoV2373
animal studies
AstraZeneca hopes warmer storage needs for COVID-19 vaccine will be an advantage against mRNA competitors
Fierce Pharma
Mon, 11/23/20 - 10:23 pm
AstraZeneca
vaccines
COVID-19
logistics
AstraZeneca's COVID-19 vaccine 70% effective, shares fall
Fierce Biotech
Mon, 11/23/20 - 10:45 am
AstraZeneca
clinical trials
COVID-19
AZD1222
Merck to acquire Oncolmmune, accelerating development of COVID-19 treatment candidate
Biopharma Reporter
Mon, 11/23/20 - 10:43 am
Merck
OncoImmune
M&A
CD24Fc
COVID-19
Clear Creek Bio doses first patient in phase 2 outpatient study of Brequinar to treat Covid-19
Pharmaceutical Business Review
Mon, 11/23/20 - 10:18 am
Clear Creek Bio
clinical trials
brequinar
COVID-19
[video+transcript]Could Late-Stage Coronavirus Vaccine Trials Fail?
Motley Fool
Mon, 11/23/20 - 10:10 am
COVID-19
vaccines
clinical trials
Regeneron COVID-19 drug, used to treat Trump, cleared for emergency use
BioPharma Dive
Sun, 11/22/20 - 11:57 pm
Regeneron
FDA
COVID-19
Emergency Use Authorization
antibodies
The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
Yahoo/Benzinga
Sun, 11/22/20 - 11:53 pm
vaccines
COVID-19
Roche
ReVance
Moderna Therapeutics
FDA
Rhythm Pharmaceuticals
Liquidia
Where Will Vaxart Be in 1 Year?
Motley Fool
Sat, 11/21/20 - 11:08 pm
Vaxart
vaccines
COVID-19
It's official: Pfizer and BioNTech have submitted their Covid-19 vaccine to the FDA -- and the agency circled a date for the adcomm
Endpoints
Sat, 11/21/20 - 11:06 pm
Pfizer
BioNTech
COVID-19
vaccines
FDA
Emergency Use Authorization
Pfizer seeking emergency use of its COVID-19 vaccine in US today
AP
Fri, 11/20/20 - 11:43 am
Pfizer
BioNTech
vaccines
COVID-19
FDA
Emergency Use Authorization
Is Inovio Back in the Coronavirus Vaccine Race?
Motley Fool
Fri, 11/20/20 - 11:16 am
Inovio Pharmaceuticals
FDA
clinical trials
vaccines
COVID-19
Adagio's COVID-19 antibody protects mice and zaps related viruses in lab tests
Fierce Biotech
Fri, 11/20/20 - 11:11 am
Adagio Therapeutics
antibodies
COVID-19
Novartis Inks $1.35 Billion Deal with Mesoblast for Remestemcel-L for COVID-19 ARDS
BioSpace
Fri, 11/20/20 - 11:08 am
Novartis
Mesoblast
remestemcel-L
COVID-19
ARDS
clinical trials
Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna
Motley Fool
Fri, 11/20/20 - 11:02 am
Pfizer
BioNTech
Moderna Therapeutics
COVID-19
vaccines
BNT162b2
mRNA-1273
JNJ
AstraZeneca
COVID-19 Vaccine Rollout Timeline: Possibly Beginning Distribution in December
BioSpace
Thu, 11/19/20 - 11:15 pm
vaccines
COVID-19
distribution
Pfizer
BioNTech
Moderna Therapeutics
Eli Lilly picks up another Covid-19 EUA as regulators wave through its Olumiant plus remdesivir combo
Endpoints
Thu, 11/19/20 - 11:09 pm
Eli Lilly
FDA
COVID-19
Emergency Use Authorization
olumiant
remdesivir
Pages
« first
‹ previous
…
107
108
109
110
111
112
113
114
115
…
next ›
last »